(Adnkronos) - “I dati Istat più recenti ci mettono al primo posto nell'export: raggiunti 54 miliardi nel 2024, con una crescita del 9,5%. Quindi, siamo la locomotiva dell'economia del Paese, impensabile fino a cinque o dieci anni fa. Il segreto è l'innovazione”. A dirlo il presidente di Farmindustria, Marcello Cattani, parlando del valore della spesa sanitaria e di quella farmaceutica per la crescita del Paese, all’Inventing for Life Health Summit - Investing for Life: la salute conta!, organizzato a Roma da Msd Italia.
Category
🗞
NewsTranscript
00:00The latest ISTAT data puts us in the first place in export, reaching 54 billion in 2024 with a growth of 9.5% and therefore we are the locomotive of the country's economy.
00:18It is unthinkable until 5-10 years ago what is the key, the secret, innovation and therefore the ability through the skills that we train and maintain to make innovation that is appreciated all over the world thanks to Made in Italy drugs.
00:34And so we must continue to look at Europe together with the government so that the European Commission Wonderland 2 is dominated by the concreteness and the speed of action to change the rules and therefore strengthen the patent that assures research, assures new drugs to European citizens and continue, as regards Italy, to add investments to the health fund, to pharmaceutical spending, the reduction of payback,
01:03the shift of the class of drugs from the direct to the conventional and to have a mechanism of early access, on the one hand, which accelerates the business path and the iter of insertion into the regions of new drugs and make sure that also the payback of 1.83 on the conventional can be exceeded,
01:27that is, the mechanism that further weights, from a financial point of view, the production of all drugs in our country, especially those great life savers that today are valued a few euros a month.
01:42The government is doing very well in this direction, the Prime Minister and the Italian Minister together, but we must do more and better as Europe because we do not have speed and authority in the proposals.
01:55If we have regulations that go against the industry, against the ability to attract competitiveness, it means that we are dominated by ideology. The United States make economy, make innovation.
02:07The DASI, if they arrive, will further strengthen the innovative tech-biotech capacity of the United States and that of China and we can look at it.
02:18We must act quickly, as they said Draghi, it is read in their report and as we now ask loudly and thanks to the support of the Italian government, which is the only stable in this moment in the European context.
02:32The time is now to focus decisively on innovation, on health and the pharmaceutical industry, which is among other things the first sector to contribute to the asset balance of export throughout Europe, 158 billion in 2023.
02:48What do we need? The numbers speak for themselves, we need concrete actions and politics today has called for this, which it has never done in the last five years.